 Suzanne Lareau
Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 30 | 2022 | 985 | 4.060 |
Why?
| | Dyspnea | 14 | 2021 | 242 | 1.470 |
Why?
| | Medication Adherence | 4 | 2020 | 558 | 0.990 |
Why?
| | Fatigue | 4 | 2023 | 318 | 0.990 |
Why?
| | Patient Education as Topic | 7 | 2018 | 743 | 0.930 |
Why?
| | Lung Diseases | 6 | 2021 | 742 | 0.910 |
Why?
| | Exercise Therapy | 6 | 2016 | 412 | 0.850 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2021 | 89 | 0.690 |
Why?
| | Activities of Daily Living | 8 | 2019 | 384 | 0.670 |
Why?
| | Cardiac Rehabilitation | 1 | 2020 | 34 | 0.640 |
Why?
| | Lung Diseases, Obstructive | 6 | 1999 | 46 | 0.630 |
Why?
| | Motor Activity | 3 | 2020 | 676 | 0.570 |
Why?
| | Disability Evaluation | 1 | 2019 | 284 | 0.540 |
Why?
| | Smoking Cessation | 2 | 2021 | 407 | 0.520 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 1052 | 0.520 |
Why?
| | Respiration | 1 | 2017 | 191 | 0.510 |
Why?
| | Patient Compliance | 2 | 2020 | 565 | 0.500 |
Why?
| | Oxygen Inhalation Therapy | 3 | 2016 | 143 | 0.500 |
Why?
| | Bronchodilator Agents | 4 | 2019 | 243 | 0.500 |
Why?
| | Self Care | 3 | 2016 | 370 | 0.500 |
Why?
| | Health Education | 1 | 2018 | 334 | 0.490 |
Why?
| | Goals | 1 | 2017 | 160 | 0.490 |
Why?
| | Patient Reported Outcome Measures | 1 | 2018 | 373 | 0.470 |
Why?
| | Respiration Disorders | 3 | 2023 | 72 | 0.460 |
Why?
| | Respiration, Artificial | 3 | 2017 | 613 | 0.460 |
Why?
| | Nebulizers and Vaporizers | 2 | 2011 | 83 | 0.460 |
Why?
| | Health Status | 3 | 2018 | 755 | 0.440 |
Why?
| | Telemedicine | 2 | 2020 | 788 | 0.440 |
Why?
| | Quality of Life | 9 | 2021 | 2704 | 0.430 |
Why?
| | Lung Neoplasms | 2 | 2022 | 2344 | 0.390 |
Why?
| | Disease Progression | 4 | 2018 | 2635 | 0.380 |
Why?
| | Heart Failure | 3 | 2020 | 2150 | 0.380 |
Why?
| | Humans | 54 | 2023 | 129650 | 0.360 |
Why?
| | Frailty | 2 | 2023 | 153 | 0.340 |
Why?
| | Surveys and Questionnaires | 11 | 2019 | 5406 | 0.310 |
Why?
| | Pamphlets | 2 | 2018 | 23 | 0.310 |
Why?
| | Delivery of Health Care, Integrated | 3 | 2018 | 248 | 0.290 |
Why?
| | Glucocorticoids | 1 | 2011 | 575 | 0.280 |
Why?
| | Critical Care | 1 | 2012 | 553 | 0.280 |
Why?
| | Critical Illness | 3 | 2018 | 758 | 0.250 |
Why?
| | Health Status Indicators | 3 | 2008 | 167 | 0.240 |
Why?
| | Self-Assessment | 1 | 2004 | 69 | 0.220 |
Why?
| | Metered Dose Inhalers | 2 | 2014 | 14 | 0.210 |
Why?
| | Pneumonectomy | 2 | 2021 | 151 | 0.200 |
Why?
| | Telerehabilitation | 1 | 2023 | 36 | 0.200 |
Why?
| | Respiratory Tract Diseases | 2 | 2023 | 148 | 0.200 |
Why?
| | Terminology as Topic | 1 | 2004 | 204 | 0.200 |
Why?
| | Exercise Tolerance | 4 | 2014 | 273 | 0.190 |
Why?
| | Chemoradiotherapy, Adjuvant | 1 | 2021 | 42 | 0.190 |
Why?
| | Walking | 1 | 2006 | 501 | 0.180 |
Why?
| | Societies, Medical | 4 | 2018 | 751 | 0.180 |
Why?
| | Reproducibility of Results | 6 | 2019 | 3083 | 0.180 |
Why?
| | Karnofsky Performance Status | 1 | 2019 | 38 | 0.160 |
Why?
| | Respiratory Therapy | 1 | 2018 | 23 | 0.150 |
Why?
| | Interdisciplinary Studies | 1 | 2018 | 29 | 0.150 |
Why?
| | Practice Guidelines as Topic | 2 | 2016 | 1501 | 0.150 |
Why?
| | Education | 1 | 2018 | 101 | 0.150 |
Why?
| | Neoplasm Staging | 1 | 2021 | 1295 | 0.140 |
Why?
| | Adrenal Cortex Hormones | 2 | 2019 | 522 | 0.140 |
Why?
| | Medical History Taking | 1 | 1998 | 119 | 0.140 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 370 | 0.140 |
Why?
| | Spirometry | 1 | 1998 | 257 | 0.140 |
Why?
| | Psychometrics | 2 | 2019 | 691 | 0.140 |
Why?
| | Equipment and Supplies | 1 | 2017 | 41 | 0.140 |
Why?
| | Muscarinic Antagonists | 1 | 2017 | 27 | 0.140 |
Why?
| | Smoking | 2 | 2021 | 1501 | 0.130 |
Why?
| | Administration, Inhalation | 3 | 2017 | 666 | 0.130 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2017 | 78 | 0.130 |
Why?
| | Lung | 5 | 2019 | 3930 | 0.130 |
Why?
| | Severity of Illness Index | 4 | 2018 | 2742 | 0.130 |
Why?
| | Comorbidity | 2 | 2022 | 1547 | 0.130 |
Why?
| | Palliative Care | 2 | 2023 | 725 | 0.120 |
Why?
| | Tonsillectomy | 1 | 2017 | 82 | 0.120 |
Why?
| | Education, Medical | 1 | 2018 | 244 | 0.120 |
Why?
| | United States | 10 | 2023 | 13903 | 0.120 |
Why?
| | Advisory Committees | 1 | 2016 | 216 | 0.110 |
Why?
| | Risk Factors | 3 | 2021 | 9765 | 0.110 |
Why?
| | Patient Safety | 1 | 2017 | 287 | 0.110 |
Why?
| | Aged | 10 | 2023 | 22103 | 0.110 |
Why?
| | Evidence-Based Medicine | 2 | 2016 | 718 | 0.110 |
Why?
| | Pulmonary Medicine | 1 | 2013 | 79 | 0.100 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2017 | 275 | 0.100 |
Why?
| | Sleep Wake Disorders | 1 | 2016 | 252 | 0.100 |
Why?
| | Health Policy | 1 | 2015 | 353 | 0.100 |
Why?
| | Myocardial Infarction | 1 | 2020 | 1022 | 0.100 |
Why?
| | History, 19th Century | 1 | 2012 | 57 | 0.100 |
Why?
| | Self Efficacy | 1 | 2016 | 374 | 0.100 |
Why?
| | Nursing | 1 | 2012 | 35 | 0.100 |
Why?
| | Intensive Care Units | 1 | 2017 | 738 | 0.090 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2012 | 89 | 0.090 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1214 | 0.090 |
Why?
| | Affective Symptoms | 1 | 2011 | 51 | 0.090 |
Why?
| | Irritable Mood | 1 | 2011 | 50 | 0.090 |
Why?
| | History, 20th Century | 1 | 2012 | 291 | 0.090 |
Why?
| | Motor Skills | 1 | 2011 | 92 | 0.090 |
Why?
| | Education, Nursing | 1 | 2012 | 90 | 0.090 |
Why?
| | Italy | 2 | 2022 | 100 | 0.090 |
Why?
| | Forced Expiratory Volume | 3 | 2008 | 510 | 0.080 |
Why?
| | Evidence-Based Practice | 1 | 2012 | 212 | 0.080 |
Why?
| | Nurse Practitioners | 1 | 2011 | 132 | 0.080 |
Why?
| | Exercise Test | 3 | 2010 | 613 | 0.080 |
Why?
| | Acute Lung Injury | 1 | 2012 | 279 | 0.080 |
Why?
| | Gastroesophageal Reflux | 1 | 2011 | 232 | 0.080 |
Why?
| | Tuberculosis | 1 | 2012 | 272 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2016 | 902 | 0.080 |
Why?
| | Respiratory Function Tests | 4 | 2008 | 586 | 0.070 |
Why?
| | Exercise | 1 | 2020 | 1925 | 0.070 |
Why?
| | Europe | 3 | 2015 | 364 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2011 | 505 | 0.070 |
Why?
| | Treatment Outcome | 6 | 2018 | 10230 | 0.070 |
Why?
| | Middle Aged | 7 | 2018 | 31154 | 0.070 |
Why?
| | Burnout, Professional | 1 | 2012 | 410 | 0.060 |
Why?
| | Physician-Patient Relations | 1 | 2010 | 539 | 0.060 |
Why?
| | Video Recording | 1 | 2006 | 164 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2018 | 7086 | 0.060 |
Why?
| | Metaphor | 1 | 2004 | 5 | 0.060 |
Why?
| | Psycholinguistics | 1 | 2004 | 20 | 0.060 |
Why?
| | Work of Breathing | 1 | 2003 | 3 | 0.050 |
Why?
| | Monitoring, Physiologic | 1 | 2006 | 268 | 0.050 |
Why?
| | Longitudinal Studies | 3 | 2003 | 2717 | 0.050 |
Why?
| | Self Disclosure | 1 | 2003 | 62 | 0.050 |
Why?
| | Male | 11 | 2022 | 63681 | 0.050 |
Why?
| | Chronic Disease | 3 | 2015 | 1720 | 0.050 |
Why?
| | Frail Elderly | 1 | 2023 | 121 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2010 | 1279 | 0.050 |
Why?
| | Adult | 3 | 2018 | 35576 | 0.050 |
Why?
| | Risk Assessment | 1 | 2010 | 3240 | 0.050 |
Why?
| | Theophylline | 1 | 2019 | 68 | 0.040 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 1 | 2019 | 35 | 0.040 |
Why?
| | Cholinergic Antagonists | 1 | 2019 | 29 | 0.040 |
Why?
| | New Zealand | 1 | 2018 | 45 | 0.040 |
Why?
| | Time Factors | 2 | 2018 | 6556 | 0.040 |
Why?
| | Australia | 1 | 2018 | 243 | 0.040 |
Why?
| | Canada | 1 | 2018 | 350 | 0.030 |
Why?
| | Program Evaluation | 2 | 2013 | 875 | 0.030 |
Why?
| | Breathing Exercises | 2 | 2006 | 20 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2018 | 216 | 0.030 |
Why?
| | Lung Transplantation | 1 | 2019 | 289 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2022 | 759 | 0.030 |
Why?
| | Polysomnography | 1 | 2017 | 174 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1996 | 173 | 0.030 |
Why?
| | Positive-Pressure Respiration | 1 | 1976 | 76 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 569 | 0.030 |
Why?
| | Patient Selection | 1 | 2019 | 663 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 894 | 0.030 |
Why?
| | Health Care Costs | 1 | 2018 | 367 | 0.030 |
Why?
| | Forced Expiratory Flow Rates | 1 | 1994 | 14 | 0.030 |
Why?
| | Total Lung Capacity | 1 | 1994 | 33 | 0.030 |
Why?
| | Ambulatory Care | 1 | 1998 | 504 | 0.030 |
Why?
| | Rehabilitation | 1 | 2013 | 16 | 0.030 |
Why?
| | International Cooperation | 1 | 2013 | 174 | 0.030 |
Why?
| | Prognosis | 2 | 2008 | 3794 | 0.030 |
Why?
| | North America | 1 | 2013 | 291 | 0.030 |
Why?
| | Models, Organizational | 1 | 2013 | 146 | 0.030 |
Why?
| | Reference Values | 1 | 1994 | 793 | 0.020 |
Why?
| | Benchmarking | 1 | 2013 | 176 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2016 | 526 | 0.020 |
Why?
| | Disease Management | 1 | 2016 | 589 | 0.020 |
Why?
| | Pediatric Nursing | 1 | 2011 | 39 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2070 | 0.020 |
Why?
| | Oxygen | 1 | 1976 | 915 | 0.020 |
Why?
| | Female | 6 | 2018 | 68776 | 0.020 |
Why?
| | Proton Pump Inhibitors | 1 | 2011 | 100 | 0.020 |
Why?
| | Asthma | 1 | 2003 | 2230 | 0.020 |
Why?
| | Taiwan | 1 | 2008 | 19 | 0.020 |
Why?
| | Brazil | 1 | 2008 | 154 | 0.020 |
Why?
| | Reference Standards | 1 | 2008 | 177 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2008 | 82 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2013 | 732 | 0.020 |
Why?
| | China | 1 | 2008 | 191 | 0.020 |
Why?
| | Relaxation Therapy | 1 | 1987 | 17 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2008 | 335 | 0.020 |
Why?
| | Nursing Assessment | 1 | 1987 | 53 | 0.020 |
Why?
| | Respiratory Muscles | 1 | 2006 | 32 | 0.020 |
Why?
| | Social Support | 1 | 2010 | 588 | 0.020 |
Why?
| | Language | 1 | 2008 | 283 | 0.020 |
Why?
| | Posture | 1 | 1987 | 176 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2005 | 55 | 0.020 |
Why?
| | Patient-Centered Care | 1 | 2010 | 505 | 0.010 |
Why?
| | Survival Analysis | 1 | 2008 | 1274 | 0.010 |
Why?
| | Quality Assurance, Health Care | 1 | 2006 | 318 | 0.010 |
Why?
| | Analgesics, Opioid | 1 | 2012 | 913 | 0.010 |
Why?
| | Program Development | 1 | 2006 | 357 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 461 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 1952 | 0.010 |
Why?
| | Respiratory Insufficiency | 1 | 2006 | 313 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2003 | 422 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2011 | 4897 | 0.010 |
Why?
| | Heart | 1 | 2006 | 637 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2003 | 516 | 0.010 |
Why?
| | Body Composition | 1 | 2006 | 649 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2003 | 1288 | 0.010 |
Why?
| | Data Collection | 1 | 2003 | 650 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3408 | 0.010 |
Why?
| | Anxiety | 1 | 2006 | 966 | 0.010 |
Why?
| | Infant | 1 | 2011 | 9024 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 5066 | 0.010 |
Why?
| | Depression | 1 | 2006 | 1307 | 0.010 |
Why?
| | Partial Pressure | 1 | 1976 | 29 | 0.010 |
Why?
| | Methods | 1 | 1976 | 64 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2006 | 1614 | 0.010 |
Why?
| | Arteries | 1 | 1976 | 265 | 0.010 |
Why?
|
|
Lareau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|